William Souillard-mandar
Investor
New York, New York
Overview
Work Experience
Investor, Advisor, Consultant
2019 - Current
Multi-strategy investments, from public markets to select startups with a focus on AI, healthcare, manufacturing (a few favorites: Anduril, Electric Era, Commonwealth Fusion Systems, Naveris, Rarecells) Venture Partner at Remus Capital Advisor at Entrepreneur First for start-ups in NYC, Paris, London, and Bangalore I also serve as a hands-on consultant/advisor to some of the companies that I back
PHD Student
2021
On leave; ML research applied to bio, health; courses in ML, computational biology
MIT CSAIL pioneers computer techniques that improve how people work, play, and learn.
Venture Partner
2019
We lead Seed-Series B rounds in technology companies. Focus on building, not betting.
REMUS is an early-stage venture capital firm that invests in companies enabling digital transformation.
Advisor
2021 - 2023
VP, AI and Analytics
2020 - 2021
We are a digital health company that seeks to leverage advances in artificial intelligence, digital biomarkers, and phenotyping to revolutionize the way users - whether healthy individuals, patients, clinicians, caregivers or researchers - take ownership of their mental and brain health.
Linus Health is a digital health company focused on improving mental health and brain health by using screening technology.
Raised $64,875,578.00 from Morningside Venture Investments.
Founding VP of Artificial Intelligence and Analytics
2015 - 2020
Company Acquired 2020 DCT is a digital health company spun out of MIT with the first FDA-cleared AI-based cognitive testing platform based on the analysis of natural behavior. The DCT platform is currently deployed in dozen of countries for pharmaceutical clinical trials and research studies, with the goals of reducing the cost to screen patients for clinical trials, serving as a cognitive outcome measure to monitor change and drug efficacy, and improving our understanding of cognition. It is also available and reimbursable for clinician use in the United States to rapidly screen and monitor patient cognitive health.
DCT develops tests that detect presymptomatic cognitive impairment and aid in tracking cognitive change.
Researcher
2012 - 2015
- Developed machine learning algorithms for understanding natural drawing behavior and detecting neurological disorders, with a focus on clinical interpretability of the system - Winner of the 2016 INFORMS Innovative Application of Analytics Award - Publication in Machine Learning Journal and presentations at NeurIPS and ICML
MIT CSAIL pioneers computer techniques that improve how people work, play, and learn.
Algorithmic Trader
2014 - 2014
J.P. Morgan Ventures Energy Corporation provides commodity risk management solutions in both the physical .
Researcher
2012 - 2012